Could a gentle surgical approach improve outcomes after deep brain bleeding?

NCT ID NCT07710313

Not yet recruiting Disease control Sponsor: Tam Anh Research Institute Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study looks at whether a minimally invasive surgical procedure can help people with a spontaneous deep brain hemorrhage (bleeding in the basal ganglia) recover better than standard medical treatment alone. Researchers will follow 300 adults for 180 days, measuring survival, functional independence, and safety. The goal is to see if this less invasive surgery reduces complications and improves quality of life after a serious stroke.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: minimally invasive surgery (a procedure to remove blood from the brain through small openings)
What this could lead to: If this approach proves effective, it could offer a safer, more precise treatment option for deep brain hemorrhages, potentially improving survival and recovery.
What could go wrong: This is an observational study, not a randomized trial, so results may be influenced by patient selection. The surgery itself carries risks like rebleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BASAL GANGLIA HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

basal ganglia cerebrovascular disorder Basal Ganglia Hemorrhage intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BASAL GANGLIA HEMORRHAGE INTRACEREBRAL HEMORRHAGE SPONTANEOUS INTRACEREBRAL HEMORRHAGE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.